Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01771991 · ClinicalTrials.gov registry record · NA
Study of Topical Superoxide Dismutase to Treat Radiation Induced Fibrosis
A NA study, sponsored by Sanford Health.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT01771991 is a NA study that has completed, run by Sanford Health. The registered enrollment target is 74 participants.
The verdict
NCT01771991, a NA study, has completed, sponsored by Sanford Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if topical superoxide dismutase is an effective treatment of radiation related neck fibrosis, and to determine the quality of life impact from radiation related fibrosis in the head and neck cancer patients at Sanford Health.
Interventions
- DRUG Placebo
- DRUG Topical Sodermix Dismutase in the form of Sodermix (SOD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01771991
The ClinicalTrials.gov registry entry for NCT01771991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01771991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01771991 about?
NCT01771991 is a clinical study titled "Study of Topical Superoxide Dismutase to Treat Radiation Induced Fibrosis". The purpose of this study is to determine if topical superoxide dismutase is an effective treatment of radiation related neck fibrosis, and to determine the quality of life impact from radiation related fibrosis in the head and neck cancer patients at Sanford Health.
What is the current status of trial NCT01771991?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01771991?
The interventions under investigation include: Placebo (DRUG), Topical Sodermix Dismutase in the form of Sodermix (SOD) (DRUG).
Who is sponsoring clinical trial NCT01771991?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.